Immunodiagnostic Market Growing Rapidly? Top Players : Abbott, DiaSorin and More

In terms of application, oncology and endocrinology segment held the largest share in the global immunodiagnostic market in 2017. Fortune Business Insights in its report, titled “Immunodiagnostics: Global Market Analysis, Insights and Forecast, 2018-2025” finds that the segment to held nearly 25.6% of the global market in 2017. According to the report, the global immunodiagnostic market was valued at US$ 15,777.5 Mn in 2017. Moreover, the global market is forecasted to exhibit 4.7% CAGR and reach US$ 22,732.7 Mn by the end of 2025. In terms of product type, the regents and consumable segment is expected to exhibit growth at a high pace during the forecast period 2018-2025.

Sample PDF Brochure at https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunodiagnostics-market-100444

KEY COMPANIES COVERED IN THE REPORT

• Abbott
• Hoffmann-La Roche AG (Roche Diagnostics)
• DiaSorin
• Danaher Corporation
• QIAGEN
• bioMérieux
• Thermo Fisher Scientific
• Quest Diagnostics

Immunodiagnostic is a new method to conduct analysis, hence its application reach is less at present. However, increasing adoption of immunodiagnostic in the diagnosis of cancer, endocrine disease, and others is likely to propel the demand in the global immunodiagnostic market.

Product launch and approval for new immunodiagnostic products and services is also expected to increase the growth rate in the global market. For instance, in 2017 the OPKO Health Inc., received approval from the U.S. Food and Drug Administration to conduct a full prostate-specific antigen text with immunoassay analyzer. Rising adoption of immunoassay analyzer will facilitate cost effectiveness and minimal steps diagnostic procedure. This is a chief driver of the market.

Rising Prevalence of Chronic Diseases to Drive the Global Market

The rising incidence of diseases such as HIV, respiratory, cancer, and others is likely to push the growth in the global immunodiagnostic market. Additionally, growing geriatric population and favorable reimbursement policies are expected to drive the global immunodiagnostic market during the forecast period 2018-2025.

North America emerged dominant in the global immunodiagnostic market in 2017. Rising investment towards research and development to find novel therapeutics and diagnosis methods for the treatment of aforementioned diseases is creating growth opportunities for the market in North America. Furthermore, government support towards these initiatives will augur well for the overall immunodiagnostics market. Asia Pacific also held a significant share in the global market. The Asia Pacific immunodiagnostic market was worth US$ 3939.1 Mn in 2017. The region is forecasted to progress at a higher CAGR. Moreover, high potential for increasing penetration of immunodiagnostics in Asia Pacific will enable growth in the regional market.

Increasing purchasing power, technological advancements, and growing demand for quality healthcare services are key factors boosting the global immunodiagnostic market. Moreover, changing patient diagnostic preference towards minimal procedure is also anticipated to fuel the demand in global market. On the downside, is lack of awareness about immunodiagnostics may restrain the market’s expansion in underdeveloped regions.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/immunodiagnostics-market-100444

Strong Supply Chain Network to Facilitate Market Players

Abbott, Roche Diagnostics, Danaher Corporation, and DiaSorin are among the leading players in the global immunodiagnostic market. Growth witnessed by these organizations is facilitated by the presence of robust supply chain network and their diverse product portfolio. Besides this, increasing investment in research and development activities and cost management by market players is helping organizations to gain higher share in the global market. Some of the other organizations operating in the global immunodiagnostic market are QIAGEN, bioMérieux, Quest Diagnostics, and Thermo Fisher Scientific.

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

This release was published on openPR.